Annual report pursuant to Section 13 and 15(d)

Nature of Business and Significant Accounting Policies (Details)

v3.19.1
Nature of Business and Significant Accounting Policies (Details)
12 Months Ended
Dec. 31, 2018
USD ($)
Nature of Business and Significant Accounting Policies (Textual)  
Nature of business, description As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 shares of our common stock; (b) options to purchase 825,000 shares of common stock of OWP Ventures at an exercise price of $0.50 automatically converted into options to purchase 825,000 shares of our common stock at an exercise price of $0.50; (c) the outstanding principal and interest under a $300,000 convertible note issued by OWP Ventures became convertible, at the option of the holder, into shares of our common stock at a conversion price equal to the lesser of $0.424 per share or 80% of the price we sell our common stock in a future "Qualified Offering"; (d) 875,000 shares of our common stock owned by OWP Ventures prior to the Merger were cancelled; and (e) OWP Ventures's chief operating officer became our chief operating officer and two of OWP Ventures's directors became members of our board of directors. OWP Colombia is currently in the process of cultivating medicinal cannabis at a facility in Popayán, Colombia for a variety of medical conditions. OWP Colombia has registered 15 varieties or strains of cannabis with the Colombian Ministry of Health and intends to register an additional 65 varieties by the end of 2019.
Accrued expenses $ 8,000
Professional fees $ 38,733